Rhumbline Advisers Axsome Therapeutics, Inc. Call Options Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
404Shares Held
37.4MCall Options Held
537KPut Options Held
602K-
Vanguard Group Inc Valley Forge, PA3.95MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$347 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$178 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$160 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$120 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.51B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...